Informations générales (source: ClinicalTrials.gov)
Hepatitis E Virus Infection in Pediatric Transplantation, a Prevalence Study (HEV)
Interventional
N/A
Hospices Civils de Lyon (Voir sur ClinicalTrials)
décembre 2013
décembre 2017
29 juin 2024
Hepatitis E virus (HEV) is an emerging disease. The genotype 1 and 2 are predominant in
Asia and Africa, and are responsible for recurrent epidemics. Genotype 3 is the main
genotype found in Europe and North America and is responsible for sporadic infections
except for travel associated diseases.
HEV had a principally asymptomatic form. However, it was recently demonstrated that it
could lead to a chronic form, especially in immunosuppressed patients. Moreover, in liver
transplanted patients the infection could mimic a rejection and lead to the loss of the
transplant. In other immunosuppressed patients, chronic hepatitis lead to cirrhosis and
its well-known complications (ascitis, digestive hemorrhage, liver failure...). There is
a lack of information about the prevalence of this disease.
In Canada the incidence of HEV infection was high (15-86% for liver transplanted children
with liver tests disturbed). In Germany the prevalence was lower: 3,2% in liver & kidney
transplanted children whereas 7,4% in control. It was shown in a retrospective study that
in liver (and liver+kidney) transplanted children the prevalence in Lyon was around 8,3%.
This study will determined in a prospective approach the HEV prevalence in kidney, lung,
heart and bone marrow transplanted children in Lyon.
Etablissements
Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
---|---|---|---|---|---|
Hospices Civils de Lyon - 69500 - Bron - France | Noémie Laverdure, MD | Contact (sur clinicalTrials) |
Critères
Tous
Inclusion Criteria:
- <18 years old
- transplantation (heart, kidney, lung or bone marrow)
- protocol acceptance by family
- social security available
- <18 years old
- transplantation (heart, kidney, lung or bone marrow)
- protocol acceptance by family
- social security available
- protocol rejection by family